Scott E. Lazerwith

1.9k total citations
14 papers, 1.1k citations indexed

About

Scott E. Lazerwith is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Scott E. Lazerwith has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Scott E. Lazerwith's work include Liver Disease Diagnosis and Treatment (4 papers), Hepatitis B Virus Studies (4 papers) and Hepatitis C virus research (4 papers). Scott E. Lazerwith is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Hepatitis B Virus Studies (4 papers) and Hepatitis C virus research (4 papers). Scott E. Lazerwith collaborates with scholars based in United States, Hong Kong and Canada. Scott E. Lazerwith's co-authors include Marya Liimatta, Douglas S. Johnson, Cory M. Stiff, Kay Ahn, Sarah E. Smith, David Beidler, Benjamin F. Cravatt, E. J. Corey, Nalini Sadagopan and Jasmina J. Allen and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Scott E. Lazerwith

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott E. Lazerwith United States 11 465 362 248 239 187 14 1.1k
Richard A. Nugent United States 15 312 0.7× 289 0.8× 356 1.4× 80 0.3× 13 0.1× 26 897
Adorján Aszalós United States 20 140 0.3× 556 1.5× 155 0.6× 115 0.5× 35 0.2× 65 1.2k
J. Castañer Spain 16 164 0.4× 296 0.8× 351 1.4× 61 0.3× 25 0.1× 125 953
Vito Nacci Italy 27 216 0.5× 759 2.1× 814 3.3× 249 1.0× 172 0.9× 48 1.6k
Marina Tintelnot‐Blomley Switzerland 17 197 0.4× 463 1.3× 217 0.9× 74 0.3× 49 0.3× 29 879
Katrina L. Creech United States 16 85 0.2× 429 1.2× 279 1.1× 121 0.5× 35 0.2× 23 1.4k
Kenneth S. Santone United States 17 67 0.1× 274 0.8× 134 0.5× 70 0.3× 27 0.1× 29 893
Per-Olof Markgren Sweden 13 90 0.2× 631 1.7× 164 0.7× 169 0.7× 128 0.7× 13 1.1k
Ramesh Gujjar United States 11 204 0.4× 416 1.1× 229 0.9× 327 1.4× 9 0.0× 12 928
Isabella Fiorini Italy 21 119 0.3× 433 1.2× 568 2.3× 121 0.5× 81 0.4× 41 950

Countries citing papers authored by Scott E. Lazerwith

Since Specialization
Citations

This map shows the geographic impact of Scott E. Lazerwith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Lazerwith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Lazerwith more than expected).

Fields of papers citing papers by Scott E. Lazerwith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott E. Lazerwith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Lazerwith. The network helps show where Scott E. Lazerwith may publish in the future.

Co-authorship network of co-authors of Scott E. Lazerwith

This figure shows the co-authorship network connecting the top 25 collaborators of Scott E. Lazerwith. A scholar is included among the top collaborators of Scott E. Lazerwith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott E. Lazerwith. Scott E. Lazerwith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Burdette, Dara, Scott E. Lazerwith, Jenny C. Yang, et al.. (2022). Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy. PLoS ONE. 17(4). e0262516–e0262516. 8 indexed citations
3.
White, Kirsten, Nathan Osman, Bluma Brenner, et al.. (2021). Long Dissociation of Bictegravir from HIV-1 Integrase-DNA Complexes. Antimicrobial Agents and Chemotherapy. 65(5). 25 indexed citations
4.
Burdette, Dara, Andrea L. Cathcart, Charlotte Hedskog, et al.. (2019). PS-150-Evidence for the presence of infectious virus in the serum from chronic hepatitis B patients suppressed on nucleos (t)ide therapy with detectable but not quantifiable HBV DNA. Journal of Hepatology. 70(1). e95–e95. 13 indexed citations
5.
Beran, Rudolf K., Dara Burdette, Dhivya Ramakrishnan, et al.. (2017). Hepatitis B virus X RNA is present in cell culture-derived virus preparations and plasma from chronically infected patients. Journal of Hepatology. 66(1). S699–S700. 1 indexed citations
6.
Tsiang, Manuel, G.S. Jones, Joshua Goldsmith, et al.. (2016). Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile. Antimicrobial Agents and Chemotherapy. 60(12). 7086–7097. 219 indexed citations
7.
Pokrovskii, Maria, Philip Morganelli, Eda Canales, et al.. (2013). A Small-Molecule Inhibitor of Hepatitis C Virus Infectivity. Antimicrobial Agents and Chemotherapy. 58(1). 386–396. 18 indexed citations
8.
Johnson, Douglas S., Cory M. Stiff, Scott E. Lazerwith, et al.. (2010). Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor. ACS Medicinal Chemistry Letters. 2(2). 91–96. 148 indexed citations
9.
Ahn, Kay, Douglas S. Johnson, Mauro Mileni, et al.. (2009). Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain. Chemistry & Biology. 16(4). 411–420. 373 indexed citations
10.
Johnson, Douglas S., Kay Ahn, Suzanne R. Kesten, et al.. (2009). Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH). Bioorganic & Medicinal Chemistry Letters. 19(10). 2865–2869. 59 indexed citations
11.
Allen, Jasmina J., Scott E. Lazerwith, & Kevan M. Shokat. (2005). Bio-orthogonal Affinity Purification of Direct Kinase Substrates. Journal of the American Chemical Society. 127(15). 5288–5289. 80 indexed citations
12.
Lazerwith, Scott E., Ted W. Johnson, & E. J. Corey. (2000). Syntheses and Stereochemical Revision of Pseudopterosin G−J Aglycon and Helioporin E. Organic Letters. 2(15). 2389–2392. 43 indexed citations
13.
Corey, E.J. & Scott E. Lazerwith. (1998). A Direct and Efficient Stereocontrolled Synthetic Route to the Pseudopterosins, Potent Marine Antiinflammatory Agents. Journal of the American Chemical Society. 120(49). 12777–12782. 53 indexed citations
14.
Corey, E. J., Angel Guzmán-Pérez, & Scott E. Lazerwith. (1997). An Enantioselective Synthetic Route to Atractyligenin Using the Oxazaborolidine-Catalyzed Reduction of β-Silyl- or β-Stannyl-Substituted α,β-Enones as a Key Step. Journal of the American Chemical Society. 119(49). 11769–11776. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard A. Nugent Breakdown of academic impact, for papers by Adorján Aszalós Breakdown of academic impact, for papers by J. Castañer Breakdown of academic impact, for papers by Vito Nacci Breakdown of academic impact, for papers by Marina Tintelnot‐Blomley Breakdown of academic impact, for papers by Katrina L. Creech Breakdown of academic impact, for papers by Kenneth S. Santone Breakdown of academic impact, for papers by Per-Olof Markgren Breakdown of academic impact, for papers by Ramesh Gujjar Breakdown of academic impact, for papers by Isabella Fiorini
Rankless by CCL
2026